Home Tags FSE:CT9

Tag: FSE:CT9

Cannabis

Cardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating Cardioprotective...

Cannabis

Cardiol Therapeutics Announces First Patient Enrolled in Phase II Study Evaluating...

Cannabis

Cardiol Therapeutics Commences Multi-Center Phase II Pilot Study of CardiolRx(TM) for...

Cannabis

Cardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

Cannabis

Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx(TM) in...

Cannabis

Cardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart Diseases

Cannabis

Cardiol Therapeutics Announces Pre-Clinical Study Results Demonstrating CardiolRx(TM) Inhibits and also...

Cannabis

Cardiol Therapeutics Announces Poster Presentation at The Annual Scientific Meeting of...

Cannabis

Cardiol Therapeutics Announces First Patient Enrolled in ARCHER, a Phase II...

Cannabis

Cardiol Therapeutics Reports Results of 2022 Annual General Meeting

1234Page 1 of 4
GrassNews digests/handpicks the latest news about the legal cannabis and CBD industries and serves them to you daily. We provide you with the latest news and press releases straight from the heart of the industry.
Get it on Google Play
Contact us: [email protected]

PICANTE Media and Events (part of Hipther Agency) is a leading media and boutique event organizer in the European Union with a monthly reach of +50,000 readers. The official company (PROSHIRT SRL), has been listed for 4 years in a row among the top 3 Advertising and market research agencies in the local Top Business Romania Microcompanies based on the Financial Reports.

Contact us: [email protected]

>Editorial / PR Submissions

Copyright © 2018 - 2022 PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania